Changing the Properties of Multipotent Mesenchymal Stromal Cells by IFNγ Administration


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

We studied changes in the population of human multipotent mesenchymal stromal cells activated by IFNγ. The cells were cultured under standard conditions; IFNγ was added in various concentrations for 4 h or over 2 passages. It was shown that the total cell production significantly decreased after long-term culturing with IFNγ, but 4-h exposure did not affect this parameter. After 4-h culturing, the expression levels of IDO1, CSF1, and IL-6 increased by 300, 7, and 2.4 times, respectively, and this increase persisted 1 and 2 days after removal of IFNγ from the culture medium. The expression of class I and II MHC (HLA) on cell surface practically did not change immediately after exposure to IFNγ, but during further culturing, HLA-ABC (MHC I) and HLA-DR (MHC II) expression significantly increased, which abolished the immune privilege in these cells, the property allowing clinical use of allogenic multipotent mesenchymal stromal cells. Multipotent mesenchymal stromal cells can suppress proliferation of lymphocytes. The degree of this suppression depends on individual properties of multipotent mesenchymal stromal cell donor. Treatment with IFNγ did not significantly affect the intensity of inhibition of lymphocyte proliferation by these cells.

作者简介

N. Petinati

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

N. Kapranov

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

A. Bigil’deev

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

M. Popova

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

Yu. Davydova

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

I. Gal’tseva

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

N. Drize

Hematology Research Center, Ministry of Health Care of the Russian Federation

编辑信件的主要联系方式.
Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

L. Kuz’mina

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

E. Parovichnikova

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow

V. Savchenko

Hematology Research Center, Ministry of Health Care of the Russian Federation

Email: ndrize@yandex.ru
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, 2017
##common.cookie##